BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8983911)

  • 1. [Progress and perspectives in palliative therapy of breast carcinoma].
    Verlag GT
    Dtsch Med Wochenschr; 1996 Dec; 121(49 Suppl):1-8. PubMed ID: 8983911
    [No Abstract]   [Full Text] [Related]  

  • 2. Taxanes in the treatment of breast cancer: a prodigy comes of age.
    Miller KD; Sledge GW
    Cancer Invest; 1999; 17(2):121-36. PubMed ID: 10071597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Paclitaxel in therapy of breast carcinoma. Value and perspectives].
    Klaassen U; Seeber S
    Med Klin (Munich); 1996 Dec; 91 Suppl 2():7-10. PubMed ID: 9082172
    [No Abstract]   [Full Text] [Related]  

  • 4. Breast cancer: adjuvant modalities.
    Sakr BJ; Dizon DS
    Clin Obstet Gynecol; 2011 Mar; 54(1):150-6. PubMed ID: 21278514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of metastatic breast carcinoma].
    Puglisi F; Sobrero A
    Ann Ital Chir; 1999; 70(3):377-89. PubMed ID: 10466241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palliative chemotherapy after failure of high-dose chemotherapy in breast cancer--toxicity and efficacy.
    Schrama JG; de Boer MM; Baars JW; Schornagel JH; Rodenhuis S
    Anticancer Res; 2003; 23(3C):2795-800. PubMed ID: 12926115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taxoids in combination chemotherapy for metastatic breast cancer.
    Dieras V; Fumoleau P; Bourgeois H; Misset JL; Azli N; Pouillart P
    Anticancer Drugs; 1996 Aug; 7 Suppl 2():47-52. PubMed ID: 8862712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal chemotherapy for women with breast cancer: the plot thickens.
    Pater JL; Pritchard KI
    J Clin Oncol; 2003 Mar; 21(6):963-4. PubMed ID: 12637457
    [No Abstract]   [Full Text] [Related]  

  • 9. Paclitaxel in doxorubicin-resistant metastatic breast cancer patients.
    Anand A; Anand A
    J Natl Cancer Inst; 1995 Nov; 87(21):1642. PubMed ID: 7563210
    [No Abstract]   [Full Text] [Related]  

  • 10. Advances in breast oncology: the 2002 ASCO meeting.
    Singh-Ranger G; Mokbel K;
    Curr Med Res Opin; 2002; 18(7):401-6. PubMed ID: 12487506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current status and the perspective of treatment strategy for the patients with advanced or recurrent breast cancer].
    Kitagawa D; Toi M
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():396-401. PubMed ID: 17682183
    [No Abstract]   [Full Text] [Related]  

  • 12. Docetaxel (Taxotere) for advanced breast cancer.
    Med Lett Drugs Ther; 1996 Sep; 38(984):87-8. PubMed ID: 8828520
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of goserelin in the treatment of breast cancer.
    Rody A; Loibl S; von Minckwitz G; Kaufmann M
    Expert Rev Anticancer Ther; 2005 Aug; 5(4):591-604. PubMed ID: 16111461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docetaxel is effective in the treatment of metastatic endometrial cancer.
    Günthert AR; Pilz S; Kuhn W; Emons G; Meden H
    Anticancer Res; 1999; 19(4C):3459-61. PubMed ID: 10629635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moving away from the "one shoe fits all" strategy: the key to future progress in chemotherapy.
    Piccart-Gebhart MJ
    J Clin Oncol; 2005 Mar; 23(8):1611-3. PubMed ID: 15755965
    [No Abstract]   [Full Text] [Related]  

  • 16. Docetaxel and epirubicin plus G-CSF as mobilizing treatment to support high-dose chemotherapy in breast cancer.
    De Rosa L; Lalle M; Perillo A; Pierelli L; Salerno MG; Cortesi E; Martelli O; Pandolfi A; Amodeo R; Marzetti L; Mancuso S; Scambia G
    Anticancer Res; 2001; 21(2B):1367-70. PubMed ID: 11396215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Docetaxel (taxotere) for therapy of breast carcinoma. Highest effectiveness with moderate side effects].
    von Minckwitz G; Costa SD
    Med Klin (Munich); 1997 Sep; 92 Suppl 4():4-9. PubMed ID: 9446016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taxing the taxanes: overused or undersold?
    Miller M
    J Natl Cancer Inst; 1999 Dec; 91(24):2077-8. PubMed ID: 10601377
    [No Abstract]   [Full Text] [Related]  

  • 19. Docetaxel-induced radiation recall dermatitis and successful rechallenge without recurrence.
    Camidge DR; Kunkler IH
    Clin Oncol (R Coll Radiol); 2000; 12(4):272-3. PubMed ID: 11005698
    [No Abstract]   [Full Text] [Related]  

  • 20. Docetaxel.
    Leahy M; Howell A
    Br J Hosp Med; 1997 Feb 19-Mar 4; 57(4):141-4. PubMed ID: 9166374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.